Policy Workshop: Life Sciences
Life Sciences: The Latest
  • EU Highlights
  • Viewpoints

European gene therapy pioneer lands $2B-plus partnership deal

uniqure NV, the Dutch company which won the first approval for a gene therapy, is taking its technology into the mainstream in a collaboration with Bristol-Myers Squibb to develop treatments for heart diseases

New initiatives launched with €365M to tackle major global health problems

A £195M fund to address antimicrobial resistance and a $100M VC fund to spur drug discovery in dementia, both announced by the UK government this week, aim to build international coalitions to deal with these threats

Europe’s €1B Human Brain Project needs urgent reform, report says

Neuroscientists say their claims that the hugely divisive project was being taken over by computer scientists have been validated

Patients should have more control over their health

Smartphones can help you understand and look after your health says Bruce Hellman, chief executive of health app start-up uMotif

Our research saves lives – if you let us

A new EU data protection law risks killing some types of medical research, researchers at the Karolinska Institutet say. Their prescription: A law that regulates Big Data, but allows for research

How to make regenerative medicine happen

Cell therapies hold the promise of more effective treatments for a range of diseases, but they face a long and expensive route to market. The key is to reduce risk and attract investors, says Keith Thompson, head of the UK Cell Therapy Catapult

Life Sciences Archive
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
"RENEW is the first study to show repair of the human central nervous system (CNS) through remyelination, and the results support...
Imperial heart attack drug research awarded 2.7m pound funding
Imperial College London has been awarded a £2.7 million grant to develop drugs that lessen the damage caused by a heart...
The UK’s most powerful solid-state Nuclear Magnetic Resonance (NMR) apparatus set to keep powering pioneering research
UK researchers will continue to gain new insights into vital high tech engineering materials and novel pharmaceuticals thanks to a new...
Imperial launches new funding scheme for experimental research projects
A new £1 million Imperial initiative which aims to fund experimental medicine proposals is now open for applications.
Aalto’s first ERC Proof of Concept grant to Sebastiaan van Dijken
Professor Sebastiaan van Dijken received the grant for verification of the innovation potential of a new racetrack memory technology.
Page 1 of 681> 1 2 3  ... 
Innovation in Progress - Science|Business Network

Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair

"RENEW is the first study to show repair of the human central nervous system (CNS) through remyelination, and the results support our ongoing development of this molecule"

Imperial heart attack drug research awarded 2.7m pound funding

Imperial College London has been awarded a £2.7 million grant to develop drugs that lessen the damage caused by a heart attack.

The UK’s most powerful solid-state Nuclear Magnetic Resonance (NMR) apparatus set to keep powering pioneering research

UK researchers will continue to gain new insights into vital high tech engineering materials and novel pharmaceuticals thanks to a new...

Horizon 2020 Special Coverage
The Role of Science in Policymaking
A high-level dinner debate on the best approaches to deal with a changing and evolving science and knowledge environment.
Brussels - 12 May 2015
2015 Global Corporate Venturing Symposium (Partner event)
The 5th annual Symposium, London June 2/3, 2015
London - 02 June 2015
Financing SMEs and growth (Date to be confirmed)
A Science|Business public conference
Brussels - 23 June 2015
Unlocking the value of Personalised Healthcare in Europe
This new study shows ICT investments could cut healthcare costs for key ailments by more than 35%.
Bigger and Simpler: A short guide to the EU's €80 billion Horizon 2020 programme
A two-year political fight formally began in Brussels on 30 November with the publication of the European Commission's plan for Horizon 2020, its omnibus R&D programme. It promises less red tape, broader benefits, and more jobs and economic growth.
Biofuels: The Next Generation
Key ideas and recommendations to accelerate the deployment of sustainable biofuels have emerged at the second in a series of three high-level academic policy debates on the energy R&D challenge, The Energy Difference
Advertisement